Gritstone's self-amplifying mRNA vaccination protected against SARS-CoV-2 challenge in NHPs Nov. 10, 2021
synTac platform delivers primary and costimulatory signals to activate virus-specific immune T cells Nov. 10, 2021
Massachusetts General Hospital to conduct preclinical trial of Angany's BP/AH-01 for peanut allergy Nov. 10, 2021
New cystic fibrosis mouse models allow testing of therapies for W1282X nonsense mutations Nov. 10, 2021
CN Bio and iiCON partner to validate novel organ-on-a-chip infection models for COVID-19 Nov. 10, 2021
Edigene and University of Wisconsin-Madison collaborate on in vivo RNA editing therapies Nov. 10, 2021
RSS